TABLE 1.
Tricyclic antidepressants |
Amitriptylinea,b,c |
Amoxapineb |
Clomipraminea,b,c |
Desipramineb |
Doxepina,b,c |
Imipraminea,b,c |
Maprotiline |
Nortriptylineb |
Protriptylineb |
Trimipraminea,b,c |
Serotonin modulators |
Nefazodone |
Trazodone |
Vilazodoned |
Vortioxetined |
Selective serotonin reuptake inhibitors |
Citalopram |
Escitalopram |
Fluoxetine |
Fluvoxamine |
Paroxetineb |
Sertraline |
Monoamine oxidase inhibitors |
Isocarboxazid |
Phenelzine |
Tranylcypromine |
Rasagilinee |
Selegilinee |
Serotonin and norepinephrine reuptake inhibitors |
Desvenlafaxine |
Duloxetine |
Levomilnaciprand |
Venlafaxine |
Milnacipranf |
Miscellaneous |
Bupropion |
Mirtazapine |
aDenotes tertiary tricyclic antidepressants.
bDenotes drugs with strong anticholinergic properties.
cIndicates that it should be avoided, regardless of diagnosis, according to 2012 or 2015 Beers Criteria.
dIndicates that it is not available in National Ambulatory Medical Care Survey.
eDenotes a monoamine oxidase B and is primarily classified as anti-Parkinsonian agents.
fIs primarily classified as fibromyalgia agents.